Multiple drug intensification after cyclophosphamide, doxorubicin, and 5-fluorouracil (CAF) induction in metastatic breast cancer: a Southeastern Cancer Study Group phase II trial.
作者信息
Vogel C L, Raney M, Carpenter J
机构信息
South Florida Cancer Center Network, AMI--Kendall Hospital Comprehensive Cancer Center, Miami 33175.
出版信息
Cancer Treat Rep. 1987 Dec;71(12):1271-3.
PMID:3690536
Abstract
摘要
相似文献
1
2
[Treatment of metastatic breast cancer].[转移性乳腺癌的治疗]
Harefuah. 1986 Jul;111(1-2):8-11.
3
4
Alternating versus sequential therapy in advanced breast cancer.
Medicina (B Aires). 1987;47(3):243-8.
5
Combination chemotherapy of breast cancer.
Mt Sinai J Med. 1985 Jun;52(6):443-6.
6
The use of adjuvant chemotherapy for breast cancer in a community practice.
Conn Med. 1985 May;49(5):281-5.
7
Phase III study of cyclophosphamide, doxorubicin, and fluorouracil (CAF) plus leucovorin versus CAF for metastatic breast cancer: Cancer and Leukemia Group B 9140.环磷酰胺、阿霉素和氟尿嘧啶（CAF）联合亚叶酸钙与CAF治疗转移性乳腺癌的III期研究：癌症与白血病B组9140研究
J Clin Oncol. 2003 May 1;21(9):1819-24. doi: 10.1200/JCO.2003.05.119.
8
Prospective evaluation of rotating chemotherapy in advanced breast cancer. An Eastern Cooperative Oncology Group Trial.
Am J Clin Oncol. 1983 Feb;6(1):1-18.
9
Natural history of more than 20 years of node-positive primary breast carcinoma treated with cyclophosphamide, methotrexate, and fluorouracil-based adjuvant chemotherapy: a study by the Cancer and Leukemia Group B.采用环磷酰胺、甲氨蝶呤和氟尿嘧啶辅助化疗治疗的20多年来淋巴结阳性原发性乳腺癌的自然病史：癌症与白血病B组的一项研究
J Clin Oncol. 2003 May 1;21(9):1825-35. doi: 10.1200/JCO.2003.09.006.
10
On the relevance of "second-line" cytotoxic chemotherapy in patients with metastatic breast cancer resistant to standard combinations.
Wien Klin Wochenschr. 1986 Dec 5;98(23):790-7.
Zotero 插件